6th Oct 2006 07:01
Stem Cell Sciences plc06 October 2006 Embargoed until 0700 6 October 2006 Stem Cell Sciences plc Notice of EGM re Possible Dual Listing The Directors of Stem Cell Sciences PLC ("SCS") or (the "Company"), thebiotechnology company focused on the commercialisation of stem cells and stemcell technologies, today announced they were intending to dual list theCompany's Ordinary Shares on the Australian Stock Exchange ("ASX") whilstcontinuing to trade on the AIM market of the London Stock Exchange ("AIM"). In conjunction with a listing, which the Directors believe will improveliquidity in the stock, the Company intends to raise additional funds to supportthe continued growth of the business. The Directors have convened an extraordinary general meeting of the shareholdersof the Company for 1 November 2006 to seek the approval of the shareholders toproceed with the proposed dual listing on the ASX, fund raising, to approve theshare sub-division and for any other related matters. This announcement shall not constitute an offer to sell or the solicitation ofan offer to buy ordinary shares in any jurisdiction. - Ends - For further information, please contact: Stem Cell Sciences plc 0131 662 9829Peter Mountford, President and CEOHugh Ilyine, Chief Operations OfficerSue Furber, Director of Finance Weber Shandwick | Square Mile 020 7067 0700Rachel Taylor/Alex Brown This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SThree